- Home
- ALT vs SFST Comparison
ALT vs SFST Comparison
Compare ALT & SFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALT | SFST |
|---|---|---|
| Founded | 1997 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 421.9M |
| IPO Year | 2005 | 2012 |
Fundamental Metrics
Financial Performance| Metric | ALT | SFST |
|---|---|---|
| Price | $3.51 | $51.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | $15.50 | ★ $64.00 |
| AVG Volume (30 Days) | ★ 2.9M | 69.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.37 | ★ 94.76 |
| EPS | N/A | ★ 3.72 |
| Revenue | $41,000.00 | ★ $6,282,000.00 |
| Revenue This Year | N/A | $10.47 |
| Revenue Next Year | $756,308.50 | $12.19 |
| P/E Ratio | ★ N/A | $14.21 |
| Revenue Growth | ★ 105.00 | 12.99 |
| 52 Week Low | $2.91 | $29.80 |
| 52 Week High | $7.73 | $62.00 |
Technical Indicators
Market Signals| Indicator | ALT | SFST |
|---|---|---|
| Relative Strength Index (RSI) | 33.42 | 36.04 |
| Support Level | $3.40 | $50.27 |
| Resistance Level | $4.25 | $52.60 |
| Average True Range (ATR) | 0.24 | 2.09 |
| MACD | -0.06 | -0.66 |
| Stochastic Oscillator | 7.07 | 15.28 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.